Intelligent Bio Solutions (INBS) Competitors $1.25 -0.03 (-1.95%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock INBS vs. DRIO, MDAI, PTHL, NMTC, TMDIF, FEMY, PYPD, OSRH, QTI, and RVPShould you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include DarioHealth (DRIO), Spectral AI (MDAI), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), Femasys (FEMY), PolyPid (PYPD), OSR (OSRH), QT Imaging (QTI), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry. Intelligent Bio Solutions vs. DarioHealth Spectral AI Pheton Holdings Ltd Class A Ordinary Shares NeuroOne Medical Technologies Titan Medical Femasys PolyPid OSR QT Imaging Retractable Technologies Intelligent Bio Solutions (NASDAQ:INBS) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Which has more volatility and risk, INBS or DRIO? Intelligent Bio Solutions has a beta of 4.63, indicating that its share price is 363% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Is INBS or DRIO more profitable? DarioHealth has a net margin of -205.62% compared to Intelligent Bio Solutions' net margin of -323.79%. DarioHealth's return on equity of -72.16% beat Intelligent Bio Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Intelligent Bio Solutions-323.79% -146.03% -83.62% DarioHealth -205.62%-72.16%-40.74% Which has higher valuation and earnings, INBS or DRIO? Intelligent Bio Solutions has higher earnings, but lower revenue than DarioHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntelligent Bio Solutions$2.94M2.95-$10.16MN/AN/ADarioHealth$27.04M1.14-$59.43M-$0.56-1.25 Do institutionals and insiders hold more shares of INBS or DRIO? 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 0.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 10.9% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer INBS or DRIO? DarioHealth has a consensus target price of $2.00, indicating a potential upside of 185.71%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts clearly believe DarioHealth is more favorable than Intelligent Bio Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DarioHealth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community favor INBS or DRIO? DarioHealth received 240 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. CompanyUnderperformOutperformIntelligent Bio SolutionsN/AN/ADarioHealthOutperform Votes24067.04% Underperform Votes11832.96% Does the media refer more to INBS or DRIO? In the previous week, Intelligent Bio Solutions and Intelligent Bio Solutions both had 6 articles in the media. Intelligent Bio Solutions' average media sentiment score of 1.09 beat DarioHealth's score of -0.30 indicating that Intelligent Bio Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intelligent Bio Solutions 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DarioHealth 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDarioHealth beats Intelligent Bio Solutions on 10 of the 14 factors compared between the two stocks. Get Intelligent Bio Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INBS vs. The Competition Export to ExcelMetricIntelligent Bio SolutionsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.67M$4.48B$5.36B$8.39BDividend YieldN/A43.64%5.22%4.10%P/E RatioN/A29.8826.5919.72Price / Sales2.9568.40391.61116.20Price / CashN/A51.0838.2534.62Price / Book1.576.236.794.51Net Income-$10.16M$68.16M$3.23B$248.18M7 Day Performance-2.33%18.37%4.03%1.14%1 Month Performance3.72%23.09%12.22%15.07%1 Year Performance-45.67%20.69%16.76%6.59% Intelligent Bio Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INBSIntelligent Bio Solutions0.4945 of 5 stars$1.26-2.0%N/A-47.8%$8.67M$2.94M0.0010Gap UpDRIODarioHealth1.6745 of 5 stars$0.76+1.3%$1.50+97.4%-60.8%$31.59M$27.04M-0.81200News CoverageEarnings ReportAnalyst ForecastMDAISpectral AI2.9187 of 5 stars$1.36+9.7%$4.75+249.3%-26.1%$31.39M$29.58M-2.0983Positive NewsAnalyst RevisionGap UpPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$4.76+8.4%N/AN/A$31.33M$448,196.000.0011High Trading VolumeNMTCNeuroOne Medical Technologies2.3359 of 5 stars$0.62+1.2%$1.45+132.8%-40.8%$29.51M$5.75M-2.4020Gap UpHigh Trading VolumeTMDIFTitan MedicalN/A$0.26-4.3%N/A+771.4%$29.43M$17.63M-0.2150Gap UpFEMYFemasys2.2601 of 5 stars$1.08+1.9%$10.00+825.9%-14.3%$29.42M$1.63M-1.3330PYPDPolyPid2.1727 of 5 stars$2.85+2.9%$11.33+297.7%-34.5%$29.04MN/A-0.5780Earnings ReportHigh Trading VolumeOSRHOSRN/A$1.25flatN/AN/A$24.10M$4.89B0.00N/APositive NewsEarnings ReportGap UpQTIQT ImagingN/A$0.86-1.1%N/A+5.7%$23.34M$4.00M0.00N/ANews CoverageGap DownRVPRetractable TechnologiesN/A$0.76+0.9%N/A-21.3%$22.67M$33.05M-1.40240Gap Up Related Companies and Tools Related Companies DRIO Competitors MDAI Competitors PTHL Competitors NMTC Competitors TMDIF Competitors FEMY Competitors PYPD Competitors OSRH Competitors QTI Competitors RVP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INBS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INBS Stock Free INBS Stock Alerts